Shang Hai Zheng Quan Bao·2025-11-06 18:46Core Viewpoint - Northeast Pharmaceutical has successfully implemented a model where employee welfare is directly linked to corporate performance, resulting in shared growth and enhanced operational efficiency since the company's mixed-ownership reform in 2018 [1][2][4] Group 1: Employee Welfare and Corporate Performance - The company has distributed over 12 billion yuan in employee benefits and bonuses since the mixed-ownership reform, significantly boosting employee motivation and engagement [2] - In 2024, the company's net profit attributable to the parent company is projected to be 4.1 billion yuan, with a year-on-year growth of 14.34%, while the net profit after deducting non-recurring gains and losses is expected to reach 3.12 billion yuan, growing by 18.97% [2] Group 2: Talent Development and Innovation - Northeast Pharmaceutical emphasizes talent development, conducting 410 specialized training sessions covering 42,000 participants in 2024, and has established a mentorship system to accelerate the growth of new employees [3] - The company has achieved 174 national patents through employee-led innovation initiatives, demonstrating a strong commitment to transforming human resources into valuable talent [3] Group 3: Workplace Environment and Employee Engagement - The company has invested 15 billion yuan in green factory renovations and has created various employee engagement facilities, fostering a workplace environment that feels like home [4] - An interactive mechanism has been established to address employee suggestions, resulting in over 6,700 proposals processed, with 4,500 successfully implemented [4]